Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;18(12):70.
doi: 10.1007/s11883-016-0627-9.

Threshold and Target for Blood Pressure Lowering in the Elderly

Affiliations
Review

Threshold and Target for Blood Pressure Lowering in the Elderly

Guido Grassi et al. Curr Atheroscler Rep. .

Abstract

Purpose of review: Detection of elevated blood pressure values in elderly patients represents a common clinical condition associated with an increased cardiovascular risk. This has been shown to be the case in both systodiastolic and isolated systolic hypertension as well. However, despite the evidence of the benefits of the blood pressure lowering intervention in terms of reduction of cardiovascular morbidity and mortality, at least two issues related to antihypertensive drug treatment in aged individuals are still undefined: (1) the blood pressure threshold at which antihypertensive drug should be initiated and (2) the blood pressure goals of the therapeutic intervention.

Recent findings: The present paper will critically review the evidence available so far on these two issues as well as the position of current guidelines and consensus statements. Emphasis will be given to the analysis of the new data of the Systolic Blood Pressure Interventional Trial (SPRINT), which have recently demonstrated the benefits, even in individuals aged more than 75 years, of a tight blood pressure reduction to systolic blood pressure to 120 mmHg or less. The potential limitations of the trial will be also critically addressed and the expectations of ongoing clinical studies investigating the issue in elderly patients properly emphasized. Although of interest, the results of the SPRINT trial encompass a number of limitations which limit their applicability to the general elderly hypertensive population. A prudent approach will be to adopt in clinical practice the less intensive and more conservative targets recommended by current guidelines.

Keywords: Antihypertensive drug treatment; Cardiovascular risk; Clinical trials; Elderly; Guidelines; Hypertension; Target blood pressure.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Lancet. 1997 Sep 13;350(9080):757-64 - PubMed
    1. JAMA. 1991 Jun 26;265(24):3255-64 - PubMed
    1. J Hypertens. 1998 Dec;16(12 Pt 1):1823-9 - PubMed
    1. J Hypertens. 2003 May;21(5):875-86 - PubMed
    1. Hypertension. 2016 Feb;67(2):261-2 - PubMed

Substances

LinkOut - more resources

Feedback